Phase I Study of SM2275 Injection in Patients With Advanced Solid Tumors
Clinical trial NCT07750132 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07750132
- Sponsor
- Beijing StarMab Biomed Technology Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-08-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.